SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director acquired 3,167 shares through a routine vesting of Restricted Stock Units (RSUs), which is a non-market transaction and a neutral indicator of insider sentiment.
• Market Impact: The transaction is considered immaterial and is unlikely to have any impact on the stock price or trading volume.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	SERVICES-MEDICAL LABORATORIES

Insider Information

Field	Value
Name	MIGNONE ROBERTO
CIK	0001258394
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-21
Transaction Code	M (Exercise/Conversion of Derivative)
Security Type	Common Stock
Shares Involved	3,167
Price Per Share	$0.00
Total Value	$0
Shares Owned After	3,167
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	3,167
% of Shares Outstanding	0.0025%
Post-Transaction Ownership	3,167 shares (0.0025% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction has a reported value of $0 and involves a number of shares that is insignificant relative to Guardant Health's $8.42 billion market capitalization.
• Ownership Concentration: The director's resulting ownership of 3,167 shares constitutes a very small fraction (0.0025%) of the total shares outstanding, indicating low concentration from this individual.
• Dilution Impact: This transaction is the realization of a prior equity grant. The vesting of 0.0025% of outstanding shares has a negligible dilutive effect on existing shareholders.
• Transaction Significance: Based on the transaction's value (0% of market cap) and share volume (0.0025% of outstanding shares), its significance is objectively low. It is a routine part of an executive compensation package.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is a vesting of RSUs, not an open-market purchase or sale. Such events are pre-scheduled as part of compensation and do not reflect new investment decisions by the insider.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction did not occur on the open market and is too small to influence trading patterns.
• Sentiment Indicator: Neutral. This filing provides no new information about the insider's confidence in the company's future prospects.

Investment Insights

Positive Market Indicators

• None can be derived from this filing.

Risk Factors

• None can be derived from this filing.

Key Takeaways

1. The transaction was the vesting of RSUs, a standard form of equity compensation.
2. It was not an open-market trade and therefore does not signal a change in insider sentiment.
3. The size of the transaction is immaterial relative to the company's market capitalization and total shares outstanding.

Additional Context

Transaction Notes

• The filing documents the conversion of 3,167 Restricted Stock Units into an equal number of common stock shares upon vesting.
• Special Circumstances: As per Footnote 1, these RSUs were granted on November 8, 2024, and this transaction represents the first 25% tranche vesting on the one-year anniversary of the vesting commencement date (October 21, 2024).